Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan + amlodipine fixed-dose combinations versus amlodipine monotherapy in essential hypertension
2007-002409-36Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of telmisartan and amlodipine in essential hypertension (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Change from baseline in seated trough diastolic blood pressure at week 8 and Incidence of oedema adverse events. Started Aug 2007; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2007-002409-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002409-36.